Ico Institut Catala D Oncologia

Granvia de L'hospitalet 199-203 08908

0 studies enrolling now · 1 studies all time

What they study most

Chronic Graft-versus-host-disease

Studies at this site

• A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease — Running, not enrolling